Worth reading
65In focus
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
500000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of the 16th Series Stock Acquisition Rights issued through a third-party allotment, with an exercise price adjustment clause
発行・処分する株式数
500,000 new shares (number of shares delivered in April 2026)
Intended allottee
Macquarie Bank Limited (allottee of the previously issued stock acquisition rights)
発行済株式総数
0.2% (exercise ratio subject to exercise restrictions)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
The exercise prices in April 2026 were ¥23.0, ¥24.0, ¥25.0 and ¥40.0. The terms provide for adjustment to an amount equivalent to 92% of the closing price. The floor for adjustments is Not disclosed.
Number of Stock Acquisition Rights
Total issued: 50,000 rights; exercised during April 2026: 5,000 rights; unexercised at month-end: 45,000 rights
Basis for determining the amount to be paid
Adjusted to an amount equivalent to 92% of the closing price on the trading day preceding the date on which the company receives notice of each exercise request, with amounts below ¥1 rounded down. However, if no adjustment is made on that date, the immediately preceding closing price applies.
Procedures under the Corporate Code of Conduct
Report on compliance with the exercise restrictions under Article 434 of the Listing Regulations. The total number of shares delivered across all series was 500,000, the number of listed shares at the time the issue proceeds were paid in was 239,821,340, and the exercise ratio subject to the exercise restrictions was 0.2%.
Most recent equity financing
16th Series Stock Acquisition Rights issued on 9 April 2025 (third-party allotment, with exercise price adjustment clause)
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the 16th Series Stock Acquisition Rights issued through a third-party allotment, with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | 500,000 new shares (number of shares delivered in April 2026) |
| Intended allottee | Macquarie Bank Limited (allottee of the previously issued stock acquisition rights) |
| Dilution Rate | 0.2% (exercise ratio subject to exercise restrictions) |
| Total number of issued shares | 294,621,340 shares (as of the end of the month preceding the target month) → Not disclosed |
| Basis for determining the amount to be paid | Adjusted to an amount equivalent to 92% of the closing price on the trading day preceding the date on which the company receives notice of each exercise request, with amounts below ¥1 rounded down. However, if no adjustment is made on that date, the immediately preceding closing price applies. |
| Exercise price | The exercise prices in April 2026 were ¥23.0, ¥24.0, ¥25.0 and ¥40.0. The terms provide for adjustment to an amount equivalent to 92% of the closing price. The floor for adjustments is Not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 50,000 rights; exercised during April 2026: 5,000 rights; unexercised at month-end: 45,000 rights |
| Procedures under the Corporate Code of Conduct | Report on compliance with the exercise restrictions under Article 434 of the Listing Regulations. The total number of shares delivered across all series was 500,000, the number of listed shares at the time the issue proceeds were paid in was 239,821,340, and the exercise ratio subject to the exercise restrictions was 0.2%. |
| Most recent equity financing | 16th Series Stock Acquisition Rights issued on 9 April 2025 (third-party allotment, with exercise price adjustment clause) |
Items this document does not state (18)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company is reporting the monthly exercise status, but does not state the reasons for the exercises or the use of proceeds.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.